Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II 2020-06-12 20:00
World's first iLDC enabling ADC drug receives IND clearance by the US FDA 2020-06-11 17:10
ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities 2020-06-10 23:03
CellResearch Corporation - Source of cGMP Umbilical Cord Lining Stem Cells for COVID-19 Related Investigator Initiated Clinical Trials 2020-06-10 21:00
Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody 2020-06-10 08:40
Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer 2020-06-09 10:10
Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies 2020-06-09 07:30
Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer 2020-06-08 20:00
Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020 2020-06-08 19:00
Healios Successfully Establishes Proprietary Universal Donor Cell Research Line 2020-06-05 13:00
PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine's existing assets to non-oncology areas 2020-06-04 00:00
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis 2020-06-03 14:30
Firmenich Appoints Boet Brinkgreve as President Ingredients 2020-06-02 23:41
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type) 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma 2020-06-01 07:30
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies 2020-05-31 20:00
I-Mab Announces Upcoming Participation at June Conferences 2020-05-29 20:00
Seaweed Extract Offers Hope for Influenza A 2020-05-28 15:30
IntegriCulture Inc. Closes Series A Fundraising Round Led by Beyond Next Ventures at JPY800 Million 2020-05-28 13:00
1 127 128 129 130 131 227